Alan Lescht & Associates, P.C.
Call 202-536-3315 Se habla espaƱol

Posts tagged "qui tam"

Understanding Qui Tam whistleblower claims

Qui tam claims filed under the False Claims Act allow certain employees and other interested parties to file suit against an entity that is defrauding the federal government. When qui tam claims are filed, they are filed on behalf of the federal government, even though the individual who has obtained evidence of fraud is acting practically as plaintiff. These kinds of lawsuits empower both individuals with knowledge of fraud and the government itself to hold fraudulent parties accountable and to recover compensation as a result of a successful suit.

Whistleblower suits can bring high rewards

The San Francisco Chronicle reports that the Corporate Whistle Blower Center-a national firm specializing in whistleblower advocacy and protection-recently urged Wall Street executives and managers who have substantial proof of securities fraud in their corporation to come forward with claims

SEC approves creation of whistleblower program

The Business Insider reports that the Securities and Exchange Commission announced last week that it would be proposing rules to create a whistleblower program designed to repay those tip off the agency to violations and allow for successful enforcement actions.

DOJ joins whistleblower suit against EDMC

The New York Times reports that the Department of Justice and several states plan on joining in a qui tam suit against Education Management Corporation (EDMC), in which the for profit college company has been accused of fraudulent practices with respect to how it compensates its recruiters.

Novartis Settles Off-Label Drug Marketing and Kickback Violations

The Department of Justice ("DOJ") has announced that a two-pronged federal investigation against Novartis Pharmaceuticals Corporation focusing on the company's unlawful off-label marketing activities and bribery of medical professionals in connection with the anti-seizure drug Trileptal settled on September 30. Novartis agreed to pay $422.5 million to resolve the civil liability charges and the criminal charges brought against it under the whistleblower provisions of the False Claims Act.

  • AV Preeminent
  • AVVO | Newsweek
  • Bloomberg BNA | Law 360 | Government Executive
  • Ten Leaders | WUSA 90
  • SuperLawyers | Univision
  • Washingtonian | abc7 | The Washington Post
  • Lead Counsel Rated
  • Top Rated Lawyers AV | ThreeBest Rated
  • AV Preeminent
  • AVVO | Newsweek
  • Bloomberg BNA | Law 360 | Government Executive
  • Ten Leaders | WUSA 90
  • SuperLawyers | Univision
  • Washingtonian | abc7 | The Washington Post
  • Lead Counsel Rated
  • Top Rated Lawyers AV | ThreeBest Rated
I have been a litigator for close to 20 years and Alan is most certainly one of the best attorneys I have ever come across.
Mr. Lescht is an excellent Trial Lawyer, He is calm, cool, and collected.
I also appreciated Alan's frankness and his ability to identify what is important and what is not when going through a case like this.
I would highly recommend Alan to anyone who needs an exceptional and incredibly talented Employment Attorney.
Mr. Lescht is an extraordinarily responsive attorney, returning my emails and phone calls within minutes. I would absolutely recommend him to anyone who thinks they may need a lawyer. Definitely incredible work.
I was impressed with his knowledge and professionalism, and I will always be grateful for his guidance.

1050 17th Street NW | Suite 400 | Washington, DC 20036 | Phone: 202-536-3315 | Map & Directions